Skip to main content

Novanta Inc.

corporate_fare Company Profile

Novanta Inc.

NOVT·NASDAQ·Manufacturing·CIK 0001076930

Novanta Inc. is a global supplier of core technology solutions for medical, life science, and advanced industrial original equipment manufacturers (OEMs). The company provides proprietary technology solutions by leveraging expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery to address complex technical challenges. Novanta engineers solutions that offer precision and performance for demanding applications. The company was founded in 1968 as General Scanning, Inc. and later merged with Lumonics Inc. in 1999, becoming GSI Lumonics Inc. In 2005, the name changed to GSI Group Inc. Through divestitures and acquisitions, the company shifted its focus from the semiconductor industry to developing and supplying components and sub-systems for medical and advanced industrial markets. The company adopted its current name, Novanta Inc., in May 2016. Novanta aims to increase medical sales as a percentage of total revenue by introducing new products for medical applications like minimally invasive and robotic surgery, ophthalmology, patient monitoring, drug delivery, clinical laboratory testing, and life science equipment. It also focuses on deepening relationships with medical equipment manufacturers and pursuing medical technology acquisitions. Additionally, Novanta seeks to increase its presence in high-growth advanced industrial applications such as laser materials processing, intelligent end-of-arm robotic technology solutions, robotics, laser additive manufacturing, automation, and metrology.

Novanta Inc. (NASDAQ:NOVT) is a publicly traded company in the Manufacturing sector. Wiseek monitors NOVT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Novanta Closes $1.2B Riverpoint Medical Acquisition, Adds $854.7M in Debt
  • Officer Matthijs Glastra Files Intent to Sell Over $1 Million in Shares
  • Novanta Prices $300M Private Placement at 12.86% Discount, Diluting Shares by 6%
  • Novanta Acquires Riverpoint Medical for $1.45B to Expand Minimally Invasive Surgery Portfolio
  • Novanta to Acquire Riverpoint Medical, Expanding Medical Portfolio

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$980.6M
Net Income
$53.83M
Diluted EPS
$1.47
Op. Cash Flow
$64.06M
Free Cash Flow
$48.43M
Gross Profit
$435.28M
Operating Income
$94.01M
Cash & Equivalents
$380.87M
Total Debt
$250.83M
Debt / Equity
0.19×
Net Margin
5.5%
Shares Outstanding
35.67M sh
Source: 10-K · filed 2026-02-23 · accession 0001193125-26-064230

Dilution Risk

Low risk

Filing-implied dilution signals for NOVT, detected from its recent SEC filings · based on capital-structure filings through 2026-06-09.

1 shelf registration

Private Placement Priced · Significant Discount to Market Price

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with N →
$141.62
52-week range · as of 2026-07-27 $98.27 – $171.85
Market cap
$5.04B
Volume
498.1K (0.9× avg)
3-mo avg 538.5K
Live data · 2026-07-29 03:41 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed NOVT - Latest Insights

NOVT
Jul 27, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $142.50
Real-time Price: $141.62 info
Change: -$0.880 (-0.62%) info
Market Cap: $5.043B info
NOVT
Jul 02, 2026, 12:29 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $161.55
Real-time Price: $141.62 info
Change: -$19.93 (-12%) info
Market Cap: $5.043B info
NOVT
Jun 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $160.65
Real-time Price: $141.62 info
Change: -$19.03 (-12%) info
Market Cap: $5.043B info
NOVT
Jun 09, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $164.34
Real-time Price: $141.62 info
Change: -$22.72 (-14%) info
Market Cap: $5.043B info
NOVT
Jun 09, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $164.34
Real-time Price: $141.62 info
Change: -$22.72 (-14%) info
Market Cap: $5.043B info
NOVT
May 15, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $152.99
Real-time Price: $141.62 info
Change: -$11.37 (-7%) info
Market Cap: $5.043B info
NOVT
May 11, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $148.00
Real-time Price: $141.62 info
Change: -$6.38 (-4%) info
Market Cap: $5.043B info
NOVT
May 11, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $139.98
Real-time Price: $141.62 info
Change: +$1.64 (+1%) info
Market Cap: $5.043B info
NOVT
Apr 24, 2026, 9:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $133.02
Real-time Price: $141.62 info
Change: +$8.60 (+6%) info
Market Cap: $5.043B info
NOVT
Feb 23, 2026, 4:57 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $139.74
Real-time Price: $141.62 info
Change: +$1.88 (+1%) info
Market Cap: $5.043B info
NOVT
Feb 23, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $139.74
Real-time Price: $141.62 info
Change: +$1.88 (+1%) info
Market Cap: $5.043B info